Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-23

FDA Approved: INDAPAMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Indapamide submitted by Rising Pharma Holdings, Inc., under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indapamide (Indapamide)

Snippet

SUPPL AP for INDAPAMIDE (INDAPAMIDE)